Drug Discovery

Delali Attipoe at the DNDi explains why we need an R&D model attuned to the needs of forgotten patients.

Research and development in sleep-wake disorders has been asleep on its feet

Sitting Down With … Piper Trelstad, Head of CMC, The Bill & Melinda Gates Medical Research Institute

What does the future hold for pharma? Audrey Greenberg and Jon Zwinski give their views.

What trends and disruptions will shape the future of pharma? West’s Anya Harry gives her view.

How the pharma industry can help tackle the opioid crisis and advance treatments

Here’s how an mRNA-based approach can overcome the development challenges of designing protein therapeutics.

Researchers use AI to reprogram glioblastoma cancer cells

We interview Lars Erwig, Director of the Centre of Drug Development at Cancer Research UK, about his career.

Research suggests diabetes patients using SGLT-2 and DPP-4 inhibitors have a decreased risk of developing dementia.